Point Imaging completes angel round to build global medical imaging brand

Recently, Shanghai Point Imaging Medical Technology Co., Ltd. (hereinafter referred to as "Point Imaging") announced the completion of its angel round. This round was led by the Intellectual Property Fund managed by Shanghai STVC Group. The raised capital will be allocated to accelerate in-house manufacturing of core components and the construction of production lines, advance the registration process for Class III medical device certifications, and enhance independent R&D of AI-assisted diagnosis and treatment systems. It will also support the development of an integrated diagnostic-treatment ecosystem covering the full patient journey—screening - diagnosis - treatment - rehabilitation—and further drive innovative integration of AI technologies with precision medical equipment.

Based on the core needs of precision medicine and primary healthcare upgrade, Point Imaging has developed China's first portable low-field brain MRI device and a supporting AI-assisted diagnosis system. This innovation addresses key clinical challenges in diagnostic efficiency and accessibility. The product has achieved internationally leading performance in several critical technologies, including low-field DWI, AI-based denoising, and super-resolution fast reconstruction, and has been honored with the Translational Science Award by the International Society for Magnetic Resonance in Medicine. These solutions are widely used in scenarios such as disease screening in primary hospitals, real-time surgical navigation, bedside diagnosis for critically ill patients, and medical support in remote areas. They fill the gap left by traditional large imaging equipment in mobile diagnostic settings, creating a unique technological barrier and product advantage. To date, Point Imaging has established partnerships with multiple top-tier hospitals in China and primary medical institutions across China, achieving several "first-in-China" breakthroughs in the field of portable high-end medical equipment. Its technical strength and product practicality have gained widespread recognition in the clinical market.

Based on its proprietary low-field magnetic resonance technology, Point Imaging has developed a world-leading, portable integrated solution for precision diagnostics and treatment, reshaping the paradigm of medical imaging. This technology overcomes the limitations of traditional high-field MRI systems—such as large size, high cost, and reliance on specialized facilities—while maintaining diagnostic accuracy. By making equipment compact, portable, and affordable, Point Imaging enables advanced imaging diagnostics to be deployed in primary care settings, including community health centers and rural clinics. Compared with conventional imaging systems, this solution significantly lowers both the financial barrier for healthcare providers and the access threshold for patients. It brings transformative potential to a range of critical scenarios—such as early disease screening at the primary care level, real-time intraoperative monitoring, and bedside diagnostics for severe cases.

The core team at Point Imaging, with years of dedicated expertise in magnetic resonance imaging and AI algorithms, has developed a comprehensive product matrix that covers the entire clinical workflow—image acquisition - intelligent analysis - diagnostic recommendations - treatment assistance — all designed around addressing essential clinical needs.

• Precision Diagnostics: An integrated layout from equipment development to intelligent analysis. In the field of precision diagnosis, Point Imaging has built a complete product line covering everything from image acquisition to intelligent interpretation.

  
  

• Portable Low-field Cranial MRI Device: It enables mobile imaging acquisition without the need for a specialized shielded room, suitable for diverse scenarios such as primary healthcare, surgical navigation, and bedside diagnosis, ensuring timely and convenient diagnosis.

  
  

• AI-Assisted Diagnosis and Treatment Module: This module integrates algorithms for low-field image denoising, super-resolution reconstruction, and intelligent lesion recognition. It significantly enhances image quality and diagnostic efficiency while lowering the operational barrier for primary care physicians.

  
  

• Multimodal Image Fusion System: Supports integrated analysis with EEG, ultrasound, and other imaging data, providing comprehensive references for complex disease diagnosis and facilitating the development of precision treatment plans. Through the synergistic deployment of these products, Point Imaging offers global healthcare institutions a comprehensive one-stop solution spanning "accessible acquisition - intelligent analysis - precise diagnosis." This approach specifically addresses the critical industry challenge in primary care settings of "having equipment but lacking precise diagnostic capabilities."

  
  

• Primary Healthcare Initiative: Delivering comprehensive support from technology implementation to ecosystem empowerment. In the field of primary healthcare advancement, Point Imaging has also built a systematic support matrix to promote the equalization of medical resources.

• Lightweight Operation Terminal: Features an intuitive interface designed for primary care workflows, integrated with a remote guidance system to provide a seamless "out-of-the-box" experience.

  
  

• Remote Diagnostic Collaboration Platform: Connects primary care providers with expert consultants from top-tier hospitals, enabling real-time image-based teleconsultation. This allows patients in local communities to access high-quality diagnostic opinions without the need for referral.

  
  

• Digital Module for Primary Healthcare: Supports standardized storage and cloud synchronization of diagnostic data, providing data support for regional health management and disease prevention and control.

Amid the rapid integration of AI into the healthcare sector, the key competitive advantage in diagnostics is shifting from hardware capabilities to the synergistic power of "equipment + algorithms + data." Point Imaging's portable diagnostic platform establishes highly automated "medical data acquisition terminals" that continuously generate vast amounts of standardized, traceable clinical imaging data. This provides a reliable real-world data foundation for training and refining medical AI models, significantly enhancing the value of AI in primary care diagnostics, disease prediction, and treatment efficacy evaluation.

In the future, the company will continue to explore partnerships with global AI medical enterprises and research institutions to jointly build the next generation of intelligent diagnosis and treatment infrastructure, accelerating the implementation of a new paradigm of data-driven precision medicine.

Point Imaging aims to build a global high-end medical imaging brand originating from China, showcasing the international competitiveness of "Made in China" in the medical equipment field. Relying on the resource advantages of Shanghai's high-end medical device industry cluster, the company has launched a systematic market expansion strategy, focusing on the the primary care market in the Yangtze River Delta region. By adopting a more clinically-oriented approach, it responds to medical needs and optimizes product experience.

In the future, the company will continue to promote the in-depth expansion of the the primary care market in provinces and cities across China, while also entering emerging overseas markets, accelerating the globalization commercialization process.